GABA B receptors mediate slow synaptic inhibition in the nervous system. In transfected cells, functional GABA B receptors are usually only observed after coexpression of GABA B(1) and GABA B(2) subunits, which established the concept of heteromerization for G-proteincoupled receptors. In the heteromeric receptor, GABA B(1) is responsible for binding of GABA, whereas GABA B(2) is necessary for surface trafficking and G-protein coupling. Consistent with these in vitro observations, the GABA B(1) subunit is also essential for all GABA B signaling in vivo. Mice lacking the GABA B(1) subunit do not exhibit detectable electrophysiological, biochemical, or behavioral responses to GABA B agonists. However, GABA B(1) exhibits a broader cellular expression pattern than GABA B(2) , suggesting that GABA B(1) could be functional in the absence of GABA B(2) . We now generated GABA B(2) -deficient mice to analyze whether GABA B(1) has the potential to signal without GABA B(2) in neurons. We show that GABA B(2) Ϫ/Ϫ mice suffer from spontaneous seizures, hyperalgesia, hyperlocomotor activity, and severe memory impairment, analogous to GABA B(1) Ϫ/Ϫ mice. This clearly demonstrates that the lack of heteromeric GABA B(1,2) receptors underlies these phenotypes. To our surprise and in contrast to GABA B(1) Ϫ/Ϫ mice, we still detect atypical electrophysiological GABA B responses in hippocampal slices of GABA B(2) Ϫ/Ϫ mice. Furthermore, in the absence of GABA B(2) , the GABA B(1) protein relocates from distal neuronal sites to the soma and proximal dendrites. Our data suggest that association of GABA B(2) with GABA B(1) is essential for receptor localization in distal processes but is not absolutely necessary for signaling. It is therefore possible that functional GABA B receptors exist in neurons that naturally lack GABA B(2) subunits.
Introduction
GABA, the predominant inhibitory neurotransmitter in the mammalian nervous system, signals through ionotropic GABA A and metabotropic GABA B receptors. GABA B receptors are coupled to G-proteins and modulate synaptic transmission by activating postsynaptic inwardly rectifying Kir3-type K ϩ channels and by controlling neurotransmitter release (Bowery et al., 2002; Calver et al., 2002; Bettler et al., 2004) .
Molecular studies on GABA B receptors provide compelling evidence for heteromerization among G-protein-coupled receptors (GPCRs) (Marshall et al., 1999; Möhler et al., 2001) . Most experiments with cloned GABA B(1) and GABA B(2) subunits expressed in heterologous cells and sympathetic neurons (Filippov et al., 2000) indicate that individual subunits are functionally inert unless they are coexpressed. GABA B receptors therefore appear different from other heterodimeric GPCRs in which individual subunits are functional when expressed alone (Bouvier, 2001 ). In the GABA B heteromer, the GABA B(1) subunit binds GABA and all competitive GABA B ligands , whereas the GABA B(2) subunit is responsible for escorting GABA B(1) to the cell surface and for activating the G-protein (Margeta-Mitrovic et al., 2000 , 2001b Calver et al., 2001; Galvez et al., 2001; Pagano et al., 2001; Robbins et al., 2001) . Two GABA B(1) isoforms, GABA B(1a) and GABA B(1b) , arise by differential promoter usage (Kaupmann et al., 1997; Bettler et al., 2004) . Thus far, the data support the existence of two predominant, yet pharmacologically indistinguishable, GABA B receptors in the nervous system, the heteromeric GABA B(1a,2) and GABA B(1b,2) receptors.
GABA B(1) Ϫ/Ϫ mice do not exhibit detectable GABA B responses in a variety of experimental paradigms, demonstrating that GABA B(1) is not only essential for GABA B signaling in vitro but also in vivo (Prosser et al., 2001; Schuler et al., 2001; Quéva et al., 2003) . However, no in vivo experiment addressed whether GABA B(1) can assemble functional GABA B receptors by itself or in association with a protein other than GABA B(2) . In support of a separate role, GABA B(1) exhibits a more widespread cellular distribution than does GABA B(2) Clark et al., 2000; Ng and Yung, 2001; Burman et al., 2003; Kim et al., 2003; Kulik et al., 2003; Li et al., 2003) . Furthermore, at odds with a strict requirement of GABA B(2) for plasma membrane delivery, GABA B(1) was originally cloned by surface expression in mammalian cells (Kaupmann et al., 1997) . Additionally, GABA B(1) occasionally yields electrophysiological or biochemical responses when transfected alone into heterologous cells (Kaupmann et al., 1997 . It is therefore conceivable that GABA B(1) is functional either alone or in combination with an unknown protein. However, it remains unclear whether sporadic endogenous expression of GABA B(2) in heterologous cells is responsible for the surface expression and the responses that were seen when GABA B(1) was transfected alone.
To clarify whether GABA B(1) can participate in functional GABA B receptors in the absence of GABA B(2) , we generated mice with a loss-of-function mutation in the GABA B(2) gene. Our results show that all well known GABA B responses relate to heteromeric GABA B(1,2) receptors. Surprisingly, the experiments also reveal atypical GABA B responses in hippocampal slices of GABA B(2) -deficient mice, indicating that GABA B(1) assemblies could be operational in neurons that naturally lack GABA B(2) .
Materials and Methods

Generation and analysis of GABA B(2)
Ϫ/Ϫ mice.
GABA B(2)
Ϫ/Ϫ mice were generated in the BALB/c inbred strain using a newly established BALB/c embryonic stem (ES) cell line. A targeting construct was designed containing a neomycin resistance cassette (pRay-2; GenBank accession number U63120) flanked by 4.5 and 1.8 kb of genomic GABA B(2) DNA that was amplified from a C57BL/6 bacterial artificial chromosome. Homologous recombination was confirmed by Southern blot analysis (Fig. 1A, B) . Selected ES cell clones were microinjected into C57BL/6 blastocysts. Chimeric males were crossed with BALB/c females, resulting in an F1 generation of inbred BALB/c GABA B(2) ϩ/Ϫ mice. GABA B(2) ϩ/Ϫ mice were viable and fertile and allowed the generation of GABA B(2) Ϫ/Ϫ mice in the F2 generation. The probes used in Northern blot analysis (Fig. 1C) hybridize to exons 4 -8 and exons 11-15 upstream (5Ј probe) and downstream (3Ј probe) of the deletion, respectively (Martin et al., 2001) . For in situ hybridization (Fig. 1D) , antisense oligonucleotides corresponding to nucleotides 2039 -79 and 1810 -54 of the rat GABA B(1a) (GenBank accession number Y10369) and GABA B(2) (GenBank accession number AJ011318) cDNAs, respectively, were used. The probes were radiolabeled with [
35 S]dATP (NEG0345H; NEN, Boston, MA) using terminal deoxynucleotidyl transferase (Promega, Madison, WI). For immunoblot analysis (Fig. 1E, F ) , polyclonal antibodies directed against the C terminus of GABA B(2) (AB5394; Chemicon, Temecula, CA), the C terminus of GABA B(1) (antibody Ϫ/Ϫ mice. A, Top, GABA B(2) locus encompassing exons 8 -11, encoding part of the N-terminal and the transmembrane (TM) domains 1 and 2. Bottom, GABA B(2) allele after homologous recombination with a targeting construct containing a neomycin resistance cassette (neo) flanked by 4.5 and 1.8 kb of genomic DNA (bold lines). Exons 9 and 10 (3.5 kb, black boxes) are deleted. The Southern blot probe used in B is indicated. H, HindIII; E, EcoRI; B, BamHI. B, Southern blot analysis of EcoRI cut genomic DNA from wild-type (ϩ/ϩ), GABA B(2) ϩ/Ϫ (ϩ/Ϫ), and GABA B(2) Ϫ/Ϫ (Ϫ/Ϫ) mice. C, Top, Northern blot analysis of total brain RNA hybridized with GABA B(2) cDNA probes upstream (5Ј probe) and downstream of the deletion (3Ј probe). The probes hybridize to a band just above the 28 S ribosomal RNA (arrow) in wild-type and GABA B(2) ϩ/Ϫ , but not in GABA B(2) Ϫ/Ϫ , mice. Bottom, Blots from top panels stained with methylene blue, demonstrating equal loading of RNA. Ribosomal RNA bands (18 and 28 S) are labeled. D, In situ hybridization analysis of GABA B(1) (1, top) and GABA B(2) (2, bottom) transcripts of sagittal sections from adult wild-type and GABA B(2) Ϫ/Ϫ brains. E, Immunoblot analysis of brain extracts from adult mice using antibodies directed against C-terminal and N-terminal epitopes of GABA B(2) and GABA B(1) . Antibodies to PSD-95 control for equal loading. GABA B(1a) (1a) and GABA B(1b) (1b) proteins are indicated. F, Immunoblot analysis demonstrating the presence of GABA B(1) protein in synaptic plasma membranes (SPM) purified from the P2 pellet (P2) of brain extracts of wild-type and GABA B(2) Ϫ/Ϫ mice. Antibodies to calreticulin show that the synaptic plasma membrane fraction is free of ER proteins. Equal loading of samples was controlled with anti-syntaxin antibodies. To detect putative truncated GABA B(2) proteins, we used 15% antibodies. In all other immunoblot experiments, we used 10% SDS-PAGE.
174.1) , the N terminus of GABA B(2) (antibody N22) , and mouse calreticulin (ab4; Abcam, Cambridge, UK) were used. Monoclonal antibodies were used to detect PSD-95 (postsynaptic density protein-95) (MAB1598, Chemicon) and syntaxin (Sigma, St. Louis, MO). Blots were exposed to HRP-conjugated secondary antibodies [NA9340 (Amersham Biosciences, Little Chalfont, UK); A5545 and A0168 (Fluka, Buchs, Switzerland)] and developed using the ECL chemiluminescent detection system (RPN2016; Amersham Biosciences). Brain membrane preparations, ligand binding assays, and receptor autoradiography were performed as described previously (Olpe et al., 1990; Kaupmann et al., 1997) . Synaptic plasma membranes were isolated from the P2 pellets of brain lysates by combined flotation-sedimentation density-gradient centrifugation (Jones and Matus, 1974 (Urwyler et al., 2001) .
Immunohistochemistry. Immunoperoxidase staining was performed in brain sections of adult mice using guinea pig antisera against GABA B(2) (1:5000; AB5394; Chemicon) and GABA B(1) (1:3000; AB1531; Chemicon). Mice were deeply anesthetized with Nembutal (50 mg/kg) and perfused through the ascending aorta with 4% paraformaldehyde in 0.15 M phosphate buffer. Brains were postfixed for 3 hr, processed for antigen retrieval using microwave irradiation (Fritschy et al., 1998) , cryoprotected in sucrose, and cut at 40 m with a sliding microtome. The immunoperoxidase staining was performed using diaminobenzidine as chromogen (Fritschy et al., 1999) . Tissue from different genotypes was processed together to minimize variability attributable to the staining procedure. Sections were analyzed by light microscopy (Axioskop; Zeiss, Jena, Germany) and photographed with a high-resolution digital camera.
Electrophysiology. Transverse hippocampal slices (350-m-thick) from 3-to 4-week-old mice were prepared. Slices were maintained for 45 min at 35°C in an interface chamber containing saline equilibrated with 95% O 2 and 5% CO 2 and containing the following (in mM): 124 NaCl, 2.7 KCl, 2 CaCl 2 , 1.3 MgCl 2 , 26 NaHCO 3 , 1.24 NaH 2 PO 4 , 18 glucose, and 2.25 ascorbate. Slices were then kept for at least 45 min at room temperature before being transferred to a superfusing recording chamber. Whole-cell recordings from CA1 pyramidal cells were performed at 30 -32°C using infrared videomicroscopy to visualize cells. Patch electrodes (3-5 M⍀) were filled with a solution containing the following (in mM): 140 Cs-gluconate, 10 HEPES, pH 7.25, 10 phosphocreatine, 5 QX-314-Cl, 4 Mg-ATP, and 0.3 Na-GTP (295 mOsm). For measurements of postsynaptic holding currents (at Ϫ50 mV, in 0.5 M TTX), Csgluconate was replaced by equimolar K-gluconate, and QX-314 was omitted. Synaptic currents were elicited every 15 sec using a bipolar platinum-iridium electrode (diameter, 25 m). EPSCs were measured at Ϫ70 mV in the presence of picrotoxin (100 M). IPSCs were measured at 0 mV in the presence of kynurenic acid (2 mM). All experiments assessing presynaptic GABA B receptor function were performed in the presence of BaCl 2 (200 M) to prevent the activation of postsynaptic Kir3 channels. BaCl 2 did not affect the EPSC or IPSC amplitudes. Current-voltage (I-V) relationships were assessed by ramp-command protocols (from Ϫ40 to Ϫ140 mV, 250 msec duration) before and after the application of agonists, and the agonist-induced I-V relationship was derived by subtraction. Data were recorded with an Axopatch 200B (Axon Instruments, Union City, CA), filtered at 2 kHz, and digitized at 10 kHz. Data were acquired and analyzed with the LTP Program (W. Anderson, University of Bristol, Bristol, UK) (Anderson and Collingridge, 2001) or with pClamp8.0 (Axon Instruments). All membrane potentials were corrected for the experimentally measured liquid junction potential of 11 mV for the internal K-gluconate solution. Slope conductance was determined between Ϫ140 mV and the reversal potential. Series resistance was monitored throughout the experiments by applying a hyperpolarizing pulse, and, if it changed Ͼ15%, the data were not included in the analysis.
All values are expressed as means Ϯ SEM. Statistical comparisons were done with paired or unpaired Student's t test as appropriate, at a significance level of 0.05. GABA B receptor ligands were from Novartis. NonGABAergic drugs were from Fluka.
Electroencephalogram measurements. Electroencephalogram (EEG) measurements were performed as described previously Kaupmann et al., 2003) . The behavior of the mice, which were individually housed in wooden observation cages, was monitored with a video system. EEGs were amplified using an isolated four-channel bipolar EEG amplifier (EEG-2104; Spectralab, Maharashtra, India), recorded on a thermo recorder (MTK95; Astro-Med, West Warwick, RI), and stored on disk.
Measurement of core body temperature, locomotor activity, rotarod, and memory performance. Rectal temperature was determined to the nearest 0.1°C as described previously Kaupmann et al., 2003) . Statistical analysis was performed using repeated-measures ANOVA, followed by Fisher's least significant difference test when appropriate. Locomotor activity was recorded using a color video camera, surveying the open field, and analyzed using EthoVision 1.90 software (Noldus Information Technology, Wageningen, The Netherlands). To assess rotarod performance, mice were trained to stay on the rotarod (12 rpm) for 300 sec over two separate sessions the day before the experiment. During the test day, the length of time each mouse remained on the cylinder ("endurance time"; maximal score of 300 sec) was measured immediately before (time 0) and 1, 2, and 4 hr after the application of L-baclofen (12.5 mg/kg) or vehicle (0.5% methylcellulose). The dose of baclofen that shows maximal effects on rotarod performance was determined in previous studies . Memory performance in the passive avoidance test was performed as described previously (Venable and Kelly, 1990; Schuler et al., 2001) .
Nociceptive tests. Heat or mechanical nociceptive stimuli were used in the antinociceptive tests as described previously ). The hotplate (Eddy and Leimbach, 1953) , tail-flick (D' Amour and Smith, 1941) , and the paw-pressure tests (Randall and Selitto, 1957) are well established techniques to assess acute pain. The tail flick is a reflex response to a noxious thermal stimulus applied to the tail and is generally held to represent a spinal reflex response, whereas the hotplate response to a noxious thermal stimulus to the plantar surface of the paws is thought to involve supraspinal sites.
Results
Previous experiments showed that only GABA B(1) Ϫ/Ϫ mice generated in the inbred BALB/c genetic background are viable (Prosser et al., 2001; Schuler et al., 2001; Quéva et al., 2003) . We therefore ablated the GABA B(2) gene in BALB/c ES cells (Fig. 1A) . Southern blot analysis confirms deletion of exons 9 (81 bp) and 10 (151 bp), encoding part of the N-terminal extracellular and the first transmembrane domain of GABA B(2) (Fig. 1B) . BALB/c GABA B (2) Ϫ/Ϫ mice are viable, occur at a Mendelian ratio, and do not express detectable GABA B(2) mRNA, as shown by Northern blot analysis using hybridization probes flanking the GABA B(2) gene deletion (Fig. 1C ). This demonstrates that any truncated mRNA produced from the 5Ј part of the GABA B(2) gene is highly unstable. The complete lack of GABA B(2) mRNA is confirmed by in situ hybridization (Fig. 1D ). Hence, GABA B(2) Ϫ/Ϫ mice do not express any full-length or truncated GABA B(2) protein, as shown by immunoblotting using antibodies directed against extreme Cor N-terminal epitopes (Fig. 1E ). Immunoblot analysis further reveals that GABA B (2) ϩ/Ϫ mice express less GABA B(2) protein than wild-type mice. A densitometric analysis of in situ hybridizations from several brain sections reveals that GABA B(1) mRNA expression in GABA B (2) Ϫ/Ϫ mice is not significantly changed when compared with wild-type littermates (Fig. 1D) . However, immunoblot analysis indicates an ϳ50 and 90% reduction of GABA B(1) protein in GABA B (2) ϩ/Ϫ and GABA B(2) Ϫ/Ϫ mice, re-spectively ( Fig. 1E ). This is reminiscent of the almost complete absence of GABA B(2) protein previously seen in GABA B(1)
mice and yet again demonstrates that the two subunits crossstabilize each other (Prosser et al., 2001; Schuler et al., 2001; Quéva et al., 2003) . Despite this considerable downregulation, we clearly detect GABA B(1) protein in synaptic plasma membrane preparations of GABA B(2) Ϫ/Ϫ mice (Fig. 1F ). This indicates that in vivo some GABA B(1) protein exits the endoplasmatic reticulum (ER) in the absence of the GABA B(2) subunit.
Redistribution of GABA B(1) in GABA B(2)
؊/؊ neurons The regional and cellular distribution of GABA B subunits was investigated using antibodies recognizing GABA B(2) or the common C terminus of GABA B(1a) and GABA B(1b) (Fig. 2) . A comparison of GABA B(2) -immunoreactivity (IR) and GABA B(1) -IR in adjacent sections of wildtype mice reveals a mostly overlapping distribution throughout the brain, with strong staining in cerebellum, thalamus, and hippocampal formation ( Fig. 2A) . In GABA B (2) ϩ/Ϫ mice, GABA B(2) -IR is reduced in all brain regions, whereas GABA B(1) -IR remains similar to wild-type mice. In GABA B (2) Ϫ/Ϫ mice, a partial expression of GABA B(1) -IR is still seen in most brain regions, contrasting with the complete loss of GABA B(2) expression. At higher magnification, GABA B(1) -IR in GABA B (2) Ϫ/Ϫ mice exhibits a strikingly different cellular distribution than in wildtype mice, as illustrated for the hippocampal formation (Fig. 2B ). The homogeneous, diffuse staining of the neuropil is almost reduced to background level, whereas the cell body layers, which normally are weakly labeled in wild-type mice, now appear very prominent. In addition, some scattered hippocampal interneurons are more evident in GABA B(2) Ϫ/Ϫ than in wild-type mice. The GABA B(1) -IR prominently outlines the soma and the proximal dendrites of these isolated interneurons, shown at higher magnification in Figure  2C . Similar results were observed throughout the brain, with an apparent accumulation of GABA B(1) -IR in the soma and proximal dendrites and a corresponding reduction of neuropil staining (data not shown). This staining was specific because no GABA B(1) -IR was detected in brain sections from GABA B(1) Ϫ/Ϫ mice, which were used as a control (data not shown). It is impossible to conclusively determine whether the GABA B(1) -IR seen in GABA B(2) Ϫ/Ϫ mice is partly associated with the plasma membrane or not. However, the strong GABA B(1) -IR in proximal dendrites of scattered interneurons, as shown in the hippocampal formation (Fig.  2B , C) and the biochemical (Fig. 1F ) and electrophysiological data (see below) (see Fig. 6 ) all suggest that this is the case. Altogether, our immunohistochemical analysis suggests that GABA B(1) fails to efficiently localize at distal neuronal sites in the absence of GABA B(2) .
Radioligand binding studies in GABA B(2)
؊/؊ mice All known competitive GABA B ligands bind exclusively to the GABA B(1) subunit Kniazeff et al., 2002 Ϫ/Ϫ mice are evident throughout the brain (top). GABA B(1) -IR is retained in GABA B (2) ϩ/Ϫ mice and partly reduced in GABA B(2) Ϫ/Ϫ mice, in which it exhibits an altered cellular distribution, as seen in the hippocampus (bottom). The residual GABA B(1) -IR in GABA B(2) Ϫ/Ϫ mice is not caused by nonspecific binding of the secondary antibodies, which are the same for GABA B(1) and GABA B(2) . The specificity of the GABA B(1) antiserum was also tested in GABA B (1) Ϫ/Ϫ mice, in which no specific staining was observed (data not shown). B, Color photomicrographs of the hippocampal formation stained for GABA B(1) in adult wild-type and GABA B(2) Ϫ/Ϫ mice. The pronounced increase of IR in the CA1-CA3 pyramidal cell layer and in the dentate gyrus granule cell layer (DG) contrasts with the strong reduction in the dendritic layers [stratum oriens (so), stratum radiatum (sr), stratum lucidum (sl), and molecular layer (ml)]. C, Enlargement of the framed areas in B. Numerous interneurons, which are primarily hidden in sections from wild-type mice because of the homogeneous staining, appear more strongly labeled in GABA B(2) Ϫ/Ϫ mice but with a normal distribution and morphology. Ϫ/Ϫ mice (Fig. 3A) . The failure to detect antagonist radioligand binding at neuronal membranes from GABA B(2) Ϫ/Ϫ brains precludes agonist displacement studies. We were therefore unable to determine whether GABA B agonist affinity is lower in GABA B (2) Ϫ/Ϫ mice, as one would expect from previous recombinant work showing that GABA B(2) increases agonist affinity at GABA B(1) by ϳ100-fold (Marshall et al., 1999 (Fig. 3C,D) , reveal low but significant numbers of GABA B(1) binding sites in GABA B (2) Ϫ/Ϫ mice. Photoaffinity labeling detects both GABA B(1a) and GABA B(1b) in GABA B (2) Ϫ/Ϫ tissue ( Fig. 3B ), in agreement with the immunoblot analysis (Fig. 1E) .
We next used [ 35 S]GTP␥S binding to investigate whether the residual GABA B(1) protein in GABA B (2) Ϫ/Ϫ mice participates in functional receptors (Fig. 4) (Fig. 4) , consistent with the reduced expression levels of GABA B(1) and GABA B(2) proteins (Figs.  1E, 3) .
Loss of presynaptic GABA B functions in GABA B(2)
؊/؊ mice Electrophysiology provides a more sensitive means than [
35 S]GTP␥S binding for detecting functional GABA B receptors expressed by individual neurons. We therefore used whole-cell patch-clamp recording to examine GABA B(2) Ϫ/Ϫ mice for the presence of GABA B heteroreceptors and autoreceptors on excitatory and inhibitory terminals, respectively. We first studied excitatory synaptic transmission in the hippocampus (Fig. 5A,B) . Stimulation in the Schaffer collateral-commissural fibers induces EPSCs in CA1 pyramidal neurons. The amplitude of these EPSCs is reduced by the activation of GABA B heteroreceptors or A1 adenosine receptors that inhibit glutamate release . Accordingly, in slices from wild-type mice, both baclofen and adenosine evoke the expected depression of the EPSCs (baclofen, 74.0 Ϯ 3.2% inhibition, n ϭ 4, p Ͻ 0.01; adenosine, 85.5 Ϯ 5.3% inhibition, n ϭ 4, p Ͻ 0.01). However, only adenosine has an effect in slices from GABA B(2) Ϫ/Ϫ mice (baclofen, 0.9 Ϯ 12.6% inhibition, n ϭ 8; adenosine, 82.1 Ϯ 7.3% inhibition, n ϭ 6, p Ͻ 0.001). This demonstrates that GABA B(2) Ϫ/Ϫ mice lack functional GABA B heteroreceptors on Schaffer collateral terminals, whereas adenosine receptors are still operational and inhibit glutamate release. We next analyzed inhibitory synaptic transmission in the presence of ionotropic glutamate receptor antagonists (Fig.  5C,D) . Activation of GABA B autoreceptors on interneurons attenuates IPSCs recorded from CA1 pyramidal neurons of wildtype mice (55.3 Ϯ 5.8% inhibition; n ϭ 7; p Ͻ 0.001). In contrast, baclofen is unable to inhibit IPSCs in GABA B(2) Ϫ/Ϫ mice (Ϫ0.5 Ϯ 3.9% inhibition; n ϭ 6), although the -opioid receptor agonist [D-Ala 2 , N-Me-Phe 4 , Gly 5 -ol]-enkephalin (DAMGO) is still effective in both genotypes (wild-type, 46.5 Ϯ 4.5% inhibition, n ϭ 7, p Ͻ 0.001; GABA B(2) Ϫ/Ϫ mice, 58.1 Ϯ 3.7% inhibition, n ϭ 5, p Ͻ 0.001). These latter experiments show that hippocampal interneurons lack GABA B autoreceptors in GABA B(2) Ϫ/Ϫ mice.
GABA B receptors inhibit instead of activate K ؉ channels in GABA B(2)
؊/؊ mice Postsynaptic GABA B and adenosine receptors activate a Kir3-mediated K ϩ conductance in CA1 pyramidal neurons (Lüscher et al., 1997; Schuler et al., 2001) . The GABA B receptor-activated K ϩ conductance underlies the late IPSP (Lüscher et al., 1997 6A,B) that is blocked by the GABA B(1) antagonist CGP55845A (2 M; 93.4 Ϯ 12.5% inhibition; n ϭ 4). Surprisingly, but consistent with the strong GABA B(1) -IR observed on the soma and proximal dendrites (Fig. 2B,C) , a baclofen-induced current is also seen in CA1 pyramidal neurons of GABA B(2) Ϫ/Ϫ mice. However, baclofen elicits an inward instead of the typical outward current (Ϫ19.2 Ϯ 4.5 pA; n ϭ 9; p Ͻ 0.01) (Fig. 6A,B ). This inward current can be blocked by the GABA B(1) antagonists CGP55845A (2 M; 99.4 Ϯ 2.7% inhibition; n ϭ 8) (Fig. 6A ) and CGP62349 (4 M; 87.5 Ϯ 8.3% inhibition; n ϭ 5), the ligand that was used for autoradiographic detection of GABA B(1) (Fig. 3C) . Whereas the baclofen-induced outward current in wild-type mice is associated with a decrease in the input resistance (Ϫ93.3 Ϯ 25.8 M⍀; n ϭ 5; p Ͻ 0.05), the inward current in GABA B(2) Ϫ/Ϫ mice is associated with an increase in input resistance (35.2 Ϯ 12.1 M⍀; n ϭ 9; p Ͻ 0.05). Adenosine-induced currents are similar in wild-type and GABA B(2) Ϫ/Ϫ mice (wild-type, 67.0 Ϯ 11.1 pA, n ϭ 5, p Ͻ 0.01; GABA B(2) Ϫ/Ϫ , 51.2 Ϯ 3.8 pA, n ϭ 4, p Ͻ 0.01) (Fig.  6A,B) . The current-voltage relationship of baclofen-induced currents reveals a positive slope conductance in wild-type mice (3.0 Ϯ 0.7 nS; n ϭ 5; p Ͻ 0.05) (Fig. 6C,I ), whereas a negative slope conductance is induced in GABA B(2) Ϫ/Ϫ mice (Ϫ2.3 Ϯ 0.5 nS; n ϭ 10; p Ͻ 0.01) (Fig. 6C,I ). Consistent with the baclofeninduced increase in input resistance, a negative slope conductance indicates that baclofen application leads to the closure of ion channels in GABA B(2) Ϫ/Ϫ mice. The baclofen-induced conductance changes in wild-type and in GABA B(2) Ϫ/Ϫ mice are completely blocked by the GABA B(1) antagonist CGP55845A (2 M; wild-type, Ϫ0.2 Ϯ 0.4 nS, n ϭ 4, p Ͻ 0.05; GABA B(2) Ϫ/Ϫ , Ϫ0.01 Ϯ 0.06 nS, n ϭ 8, p Ͻ 0.001) (Fig. 6I) . Adenosine-induced conductance changes are similar in wild-type (conductance, 4.83 Ϯ 0.91 nS; n ϭ 4; p Ͻ 0.01; V rev , Ϫ94.5 Ϯ 1.2 mV; n ϭ 4) and GABA B(2) Ϫ/Ϫ (4.63 Ϯ 0.83 nS; n ϭ 4; p Ͻ 0.01; V rev , Ϫ93.5 Ϯ 2.5 mV; n ϭ 4) mice (Fig. 6D,I ). The reversal potential of the baclofen-induced current in GABA B(2) Ϫ/Ϫ cells is shifted by raising the extracellular [K ϩ ] from 2.7 mM (V rev , Ϫ96.7 Ϯ 3.6 mV; n ϭ 10; calculated V rev for K ϩ , Ϫ99.5 mV) to 20 mM (V rev , Ϫ47.6 Ϯ 7.4 mV; n ϭ 6; calculated V rev for K ϩ , Ϫ45.8 mV) (Fig.  6E ), indicating that a closure of K ϩ channels underlies the baclofen-induced conductance change in GABA B(2) Ϫ/Ϫ neurons.
Barium at a concentration of 300 M completely occludes the baclofen-induced channel closure in wild-type and GABA B(2) Ϫ/Ϫ CA1 pyramidal cells (data not shown). It is therefore conceivable that the GABA B receptors in GABA B(2) Ϫ/Ϫ CA1 neurons and the GABA B(1,2) receptors in wild-type CA1 neurons both couple to Kir3 channels but with opposite effects on channel activity. A large body of in vitro data supports that, within the heteromeric GABA B(1,2) receptor, the now-missing GABA B(2) subunit is absolutely necessary for G-protein coupling (Galvez et al., 2001; Margeta-Mitrovic et al., 2001b; Robbins et al., 2001; Duthey et al., 2002; Havlickova et al., 2002) . We therefore investigated whether the baclofen-induced closure of K ϩ channels in GABA B (2) Ϫ/Ϫ cells is mediated by G-proteins or not. We recorded postsynaptic responses in the presence of GDP␤S, which prevents G-protein activation. Intracellular dialysis of CA1 pyramidal cells from GABA B(2) Ϫ/Ϫ mice with GDP␤S (1 mM for at least 25 min) specifically blocks the induction of postsynaptic currents by baclofen (control, Ϫ19.2 Ϯ 4.5 pA, n ϭ 5; GDP␤S, 0.1 Ϯ 3.9 pA, n ϭ 5, p Ͻ 0.01) (Fig. 6F) or adenosine (control, 51.2 Ϯ 3.8 pA, n ϭ 4; GDP␤S, 2.1 Ϯ 4.9 pA, n ϭ 5, p Ͻ 0.05) (Fig. 6F) , demonstrating that the baclofen-induced conductance change in GABA B(2) Ϫ/Ϫ CA1 pyramidal cells is G-protein mediated. It is conceivable that the baclofen-induced inhibition of a K ϩ current is the consequence of a dominant-negative effect. For example, GABA B(1) activation in GABA B(2) Ϫ/Ϫ neurons may sequester G-proteins that are normally associated with other GPCR-activating K ϩ channels. Such a baclofen-dependent sequestering of G-proteins would reduce K ϩ currents and could underlie the inward current observed in GABA B (2) Ϫ/Ϫ neurons. We investigated whether baclofen can cross-inhibit the adenosine response by first applying adenosine to CA1 pyramidal cells, followed by a combined application of adenosine and baclofen (Fig. 6G,H) . In both wild-type and GABA B(2) Ϫ/Ϫ neurons, the effects of adenosine and baclofen are not fully additive, indicating that adenosine and GABA B receptors share G-proteins and/or effector K ϩ channels. However, the cross-inhibitory effect was not larger in GABA B(2) Ϫ/Ϫ than in wild-type neurons. Although the outcome of these experiments does not completely exclude sequestering, it clearly does not support it. The fact that the baclofen-induced current is blocked by GDP␤S also argues against a passive sequestering of G-proteins and shows that activation of G-proteins is necessary to trigger the inward current (Fig. 6F ). Others and we reported previously a complete loss of postsynaptic baclofen responses in GABA B(1) Ϫ/Ϫ mice (Prosser et al., 2001; Schuler et al., 2001) . We therefore reinvestigated GABA B(1) Ϫ/Ϫ mice for baclofen-induced responses under identical experimental conditions as used for the analysis of GABA B(2) Ϫ/Ϫ mice (Fig. 6I) . Consistent with our previous findings, we do not observe any postsynaptic conductance changes induced by baclofen in GABA B(1) Ϫ/Ϫ mice. Therefore, exclusively GABA B(2) Ϫ/Ϫ mice express residual functional GABA B receptors.
Lack of behavioral responses to baclofen in GABA B(2)
؊/؊ mice In addition to inducing electrophysiological responses, baclofen may also cause detectable behavioral responses in GABA B(2) Ϫ/Ϫ mice. We therefore studied well known physiological responses to baclofen in GABA B (2) Ϫ/Ϫ mice. First, we investigated whether baclofen still induces delta waves in the EEG, as shown previously for wild-type mice Kaupmann et al., 2003) . Twenty minutes after baclofen application (10 mg/kg, i.p.), delta waves appeared in the EEG of wild-type mice but not in the EEG of GABA B (2) Ϫ/Ϫ mice (Fig. 7) . Ten hours after baclofen administration, the EEG of wild-type mice reverted to normal. No significant EEG changes were observed in GABA B(2) Ϫ/Ϫ mice during the entire duration of the experiment. This indicates that the baclofen-induced electrophysiological responses in GABA B(2) Ϫ/Ϫ mice (Fig. 6 ) do not result in detectable changes of electrical activity at the network level.
We next investigated whether GABA B receptors in GABA B(2) Ϫ/Ϫ mice are able to mediate the well known muscle-relaxant effect of baclofen. Baclofen induces muscle relaxation in wild-type but not in GABA B (2) Ϫ/Ϫ mice, as shown by the inability or ability, respectively, of the mice to stay on the rotarod during a 5 min period (Fig. 8A) . Similarly, GABA B (2) Ϫ/Ϫ mice demonstrate a lack of baclofen-induced hypothermia (Fig. 8B) . Together, these data indicate that residual GABA B receptors in GABA B (2) Ϫ/Ϫ mice are unable to influence muscle relaxation or body temperature.
GABA B(2)
؊/؊ mice exhibit spontaneous epileptiform activity, hyperlocomotor activity, hyperalgesia, and impaired passive avoidance learning We reported previously that adult GABA B (1) Ϫ/Ϫ mice exhibit pronounced spontaneous epileptiform activity . We therefore investigated whether adult GABA B(2) Ϫ/Ϫ mice are epileptic and recorded continuous EEG in freely moving animals using implanted electrodes.
Ϫ/Ϫ mice displayed several episodes of spontaneous seizures per day. The analysis of three GABA B(2) Ϫ/Ϫ mice over a 96 hr period revealed an average of 3.75 (0, 11, 3, 1), 0.5 (1, 0, 0, 1), and 2.0 (3, 2, 2, 1) seizures per day. The recorded seizures were exclusively of the clonic type. This is in contrast to GABA B(1) Ϫ/Ϫ mice, in which additionally absence-type and spontaneous tonic-clonic seizures occurred with low frequency . Epileptiform activity was never observed in wild-type littermates (n ϭ 3).
GABA B(1) Ϫ/Ϫ mice exhibit a sporadic hyperlocomotor phenotype when exposed to a new environment . We similarly studied the locomotor activity of GABA B(2) Ϫ/Ϫ mice using the Ethovision recording system. During a 1 hr observation period, GABA B(2) Ϫ/Ϫ mice moved over a significantly larger distance with significantly increased speed compared with wild-type and heterozygous littermates (Fig. 9A) . These experiments demonstrate that functional GABA B receptors in GABA B(2) Ϫ/Ϫ mice do not rescue the hyperlocomotor phenotype seen with GABA B(1) Ϫ/Ϫ mice, which completely lack functional GABA B receptors.
GABA B agonists exhibit antinociceptive properties in models of acute and chronic pain (Patel et al., 2001 ). These properties are likely mediated by supraspinal and spinal GABA B receptors (Malcangio et al., 1991) . Consistent with these pharmacological findings, GABA B(1) Ϫ/Ϫ mice exhibit pronounced hyperalgesia, suggesting that GABA B receptors exert a tonic control over nociceptive processes ). We used the hotplate (Fig. 9B) , tail-flick (Fig. 9C) , and paw-pressure (Fig. 9D) tests to measure acute pain behaviors in GABA B(2) Ϫ/Ϫ mice. Similar to the GABA B(1) Ϫ/Ϫ mice, GABA B(2) Ϫ/Ϫ mice exhibit hyperalgesia in all three tests, showing significantly reduced response latencies or withdrawal thresholds when compared with wild-type or heterozygous littermate mice. In all three tests, we did not observe significant differences in the behavior of wild-type or heterozygous mice.
GABA B antagonists are reported to have profound effects on memory processing. They can either enhance (Getova and Bowery, 1998; Nakagawa et al., 1999; Stäubli et al., 1999; Getova and Bowery, 2001) or attenuate (Brucato et al., 1996) cognitive performance in a variety of learning paradigms in mice and rats. We reported previously that GABA B(1) Ϫ/Ϫ mice exhibit a severe impairment of passive avoidance learning . We therefore investigated the memory performance of GABA B(2) Ϫ/Ϫ mice (Fig. 9E) . GABA B(2) Ϫ/Ϫ mice, in contrast to wild-type mice, show no increased latency in entering the darkened shock compartment in the retention trial that followed the training trial. This indicates that GABA B(2) Ϫ/Ϫ mice exhibit an impairment of passive avoidance learning, similar to GABA B(1) Ϫ/Ϫ mice. We further observed that GABA B(2) Ϫ/Ϫ mice show increased latencies to enter the darkened shock compartment on the training trial compared with wild-type littermate mice ( p Ͻ 0.01). This excludes the possibility that GABA B(2) Ϫ/Ϫ mice have a tendency Ϫ/Ϫ (bottom, open circles) mice. Both baclofen (50 M) and adenosine (100 M) significantly depress the EPSC amplitude in wild-type mice, whereas baclofen and CGP55845A (2 M) have no effect on the EPSC amplitude in GABA B (2) Ϫ/Ϫ mice. The effect of adenosine is similar in both genotypes. Traces are averages of 10 consecutive sweeps. Calibration: 40 msec, 100 pA. B, Summary graph showing the lack of baclofen-induced presynaptic inhibition of excitatory synaptic transmission in GABA B (2) Ϫ/Ϫ mice (wild-type, n ϭ 4; GABA B(2) Ϫ/Ϫ , n ϭ 8). Adenosine-induced inhibition is similar in both genotypes (wild-type, n ϭ 4; GABA B(2) Ϫ/Ϫ , n ϭ 6). C, Inhibitory synaptic transmission. Monosynaptic IPSC peak amplitudes plotted versus time and representative traces from wild-type (top, filled circles) and GABA B(2) Ϫ/Ϫ (bottom, open circles) mice. Both baclofen (50 M) and the -opioid agonist DAMGO (1 M) significantly depress the IPSC amplitude in wild-type mice, whereas baclofen and CGP55845A (2 M) have no effect on the IPSC amplitude in GABA B(2) Ϫ/Ϫ mice. The effect of DAMGO was similar in both genotypes. Traces are averages of 10 consecutive sweeps. Calibration: 100 msec, 200 pA. D, Summary graph showing the lack of baclofen-induced presynaptic inhibition of inhibitory synaptic transmission in GABA B(2) Ϫ/Ϫ mice (wild-type, n ϭ 7; GABA B(2) Ϫ/Ϫ , n ϭ 6). DAMGO-induced inhibition was similar in both genotypes (wild-type, n ϭ 7; GABA B(2) Ϫ/Ϫ , n ϭ 5). **p Ͻ 0.01; ***p Ͻ 0.001.
to enter the dark compartment more quickly, independent of the training experience.
Discussion
Pharmacological and behavioral analyses of GABA B (2) Ϫ/Ϫ mice indicate that deletion of the GABA B(2) subunit is sufficient to abolish all well known responses to GABA B agonists, such as [
35 S]GTP␥S binding (Fig. 4) , muscle relaxation ( Fig. 8A) , hypothermia (Fig. 8B) , and EEG delta wave induction (Fig. 7) . These findings are paralleled by a loss of typical electrophysiological GABA B responses in the GABA B(2) Ϫ/Ϫ hippocampus (Figs. 5, 6 ). These results are analogous to the results obtained with GABA B (1) Ϫ/Ϫ mice and suggest that all classical GABA B responses relate to heteromeric GABA B(1,2) receptors. The heteromeric nature of predominant native GABA B receptors is further emphasized by the substantial downregulation of GABA B(1) protein in GABA B (2) Ϫ/Ϫ mice (Fig. 1E ). An analogous requirement of GABA B(1) for stable expression of GABA B(2) was observed in GABA B (1) Ϫ/Ϫ mice (Prosser et al., 2001; Schuler et al., 2001; Quéva et al., 2003) .
Strikingly, the remaining GABA B(1) protein in GABA B (2) Ϫ/Ϫ neurons accumulates in distinct cellular compartments than in wild-type neurons. Throughout the GABA B (2) Ϫ/Ϫ brain, we observed a redistribution of the GABA B(1) -IR from the neuropil to the soma (Fig. 2 and data not shown). We also noticed some scattered hippocampal interneurons that are more evident in GABA B (2) Ϫ/Ϫ than wild-type brains (Fig. 2B,C) . The GABA B(1) -IR prominently outlines the soma and proximal dendrites of these cells. This is reminiscent of the strong somatic GABA B(1) -IR observed in a subset of GABAergic hippocampal interneurons lacking GABA B(2) -IR (Fritschy et al., 1999; Sloviter et al., 1999; Kulik et al., 2003) . Presumably, both a genetically induced and a natural lack of GABA B(2) expression leads to a relocation of GABA B(1) protein to the soma and proximal dendrites. Because GABA B (2) is important for exit of GABA B(1) from the ER, most of the somatic GABA B(1) -IR likely reflects protein that fails to exit the ER. However, some of the GABA B(1) -IR on the soma and proximal dendrites may also represent GABA B(1) protein at the cell surface. This is supported by biochemical (Fig. 1F ) and electrophysiological (Fig. 6 ) data that reveal GABA B(1) expression in synaptic membranes and functional receptors in the somatodendritic compartment of CA1 pyramidal neurons, respectively. Besides being important for G-protein coupling and export from the ER (Margeta-Mitrovic et al., 2000 , 2001b Calver et al., 2001; Galvez et al., 2001; Pagano et al., 2001; Robbins et al., 2001) , GABA B(2) may therefore also be necessary for the targeting of GABA B(1,2) receptors to the distal zones of neuronal processes.
Whether a physiologically relevant signaling underlies the electrophysiological GABA B responses that we observe in CA1 neurons of GABA B (2) Ϫ/Ϫ mice is unclear. It is possible that these GABA B responses are a consequence of the knock-out situation, Ϫ/Ϫ mice. Baclofen-induced effects were blocked by application of the GABA B receptor antagonist CGP55845A (2 M) in wild-type as well as in GABA B (2) Ϫ/Ϫ mice. B, Summary graph illustrating the baclofen-induced inward current at Ϫ50 mV in GABA B(2) Ϫ/Ϫ mice. Baclofen-induced currents: wild-type, n ϭ 5; GABA B(2) Ϫ/Ϫ , n ϭ 9. Adenosine-induced currents: wild-type, n ϭ 5; GABA B(2) Ϫ/Ϫ , n ϭ 4. C, Current-voltage relationship of the baclofen-induced conductance in wild-type (black trace) and GABA B(2) Ϫ/Ϫ (gray trace) mice. Currents were obtained by calculating the difference between the I-V curves before and after addition of baclofen. Whereas a current with a positive slope conductance is induced by baclofen in wild-type mice, a current with negative slope conductance is induced in GABA B(2) Ϫ/Ϫ mice. D, Current-voltage relationship of the adenosine-induced conductance in wild-type mice (black trace) is not different from GABA B(2) Ϫ/Ϫ mice (gray trace). E, Baclofen induces the closure of K ϩ channels in GABA B(2) Ϫ/Ϫ mice. Raising extracellular [K ϩ ] concentration shifts the reversal potential of the baclofen-induced current. F, The baclofen-induced conductance change is mediated by G-protein activation. In the presence of intracellular GDP␤S (1 mM for 25 min), both the baclofen-induced (control, n ϭ 5; GDP␤S, n ϭ 5) and adenosine-induced (control, n ϭ 4; GDP␤S, n ϭ 5) currents are inhibited in GABA B(2) Ϫ/Ϫ mice. G, Changes in the holding current (at Ϫ50 mV) in response to baclofen (Bacl.) after preincubation with adenosine. H, Summary graph illustrating that the effects of adenosine and baclofen are not fully additive. In wild-type neurons (ϩ/ϩ), the effect of a combined application of adenosine and baclofen is lower than the sum of the individual effects [Adenosine ϩ Bacl. (calculated)]. In GABA B(2) Ϫ/Ϫ (Ϫ/Ϫ) neurons, the effects of adenosine and baclofen are not fully additive. Application of baclofen does not obliterate the adenosine response. I, Left, Summary graph illustrating postsynaptic conductance changes induced by baclofen in wild-type (n ϭ 5), GABA B(2) ϩ/Ϫ (n ϭ 10), and GABA B(1) Ϫ/Ϫ (n ϭ 4) mice. The conductance changes were blocked by application of the GABA B(1) receptor antagonist CGP55845A (2 M; wild-type, n ϭ 4; GABA B(2) Ϫ/Ϫ , n ϭ 8). Adenosine-induced conductance changes are not different between genotypes (wild-type, n ϭ 4; GABA B(2) Ϫ/Ϫ , n ϭ 4; GABA B(1) Ϫ/Ϫ , n ϭ 3). *p Ͻ 0.05; **p Ͻ 0.01.
mediated electrophysiological responses in GABA B(2) Ϫ/Ϫ CA1 neurons are opposite to those recorded in wild-type CA1 neurons. We addressed whether activation of GABA B(1) in GABA B(2) Ϫ/Ϫ neurons takes on a dominant-negative effect by sequestering G-proteins that normally activate Kir channels. We did not observe increased cross-inhibition of the adenosine response by baclofen in GABA B(2) Ϫ/Ϫ as opposed to wild-type neurons, rendering sequestering unlikely (Fig. 6G,H) . Further arguing against a passive sequestering of G-proteins, the baclofen-induced inward current in GABA B(2) Ϫ/Ϫ neurons is blocked by GDP␤S (Fig. 6F) . Some G-proteins are reported to inhibit rather than to activate Kir3 channels (e.g., by phospholipase C-mediated phosphatidylinositol-4, 5-biphosphate hydrolysis or PKC activation) (Schreibmayer et al., 1996; Sharon et al., 1997; Lei et al., 2000 Lei et al., , 2001 Blanchet and Lüscher, 2002; Mao et al., 2004) . Similar to what is now observed, metabotropic glutamate receptors not only activate but also inhibit K ϩ channels, presumably by coupling to distinct G-proteins (Sharon et al., 1997) . For example, they were shown to be able to suppress a barium-sensitive K ϩ current in CA3 pyramidal cells (Lüthi et al., 1997) and to downregulate Kir3 channels in Xenopus oocytes (Sharon et al., 1997) . It is therefore conceivable that the somatic redistribution of GABA B receptors (Fig. 2 ) in GABA B (2) Ϫ/Ϫ neurons leads to a promiscuous coupling to G-proteins that are not normally associated with heteromeric GABA B(1,2) receptors. This would explain why no significant [
S]GTP␥S binding is detectable in neuronal membranes from GABA B(2)
Ϫ/Ϫ mice (Fig. 4) because this assay preferentially detects G i/o -proteins that are typically associated with native GABA B(1,2) receptors. A promiscuous coupling to G-proteins in neurons may also explain why we never observed GABA B responses opposite to those of heteromeric GABA B(1,2) receptors when GABA B(1) was functional by itself in transfected cells (Kaupmann et al., 1997 . There is compelling in vitro evidence to show that, in the heteromer, the GABA B(2) subunit is necessary to engage and activate G-proteins (Galvez et al., 2001; Margeta-Mitrovic et al., 2001b; Robbins et al., 2001; Duthey et al., 2002; Havlickova et al., 2002) . GABA B(1) may therefore also function in association with another, yet unknown GPCR subunit, which couples to G-proteins other than GABA B(2) . In that respect, a GABA B receptor-related protein has been identified (Calver et al., 2003) . However, in heterologous cells, this protein does not appear to participate in typical GABA B signaling. Furthermore, because "Family C" GPCRs preferentially assemble homodimers, the existence of homodimeric GABA B(1) receptors cannot be excluded (Bouvier, 2001) . It is possible that homodimeric GABA B(1) receptors couple to G-proteins other than heterodimeric GABA B(1,2) receptors. Moreover, they may exhibit a constitutive activity that can be inhibited by agonists. Of note, it was reported that chimeric GABA B receptors with two GABA B(1) extracellular domains exhibit an increased basal activity and, for unknown reasons, respond to GABA agonists with inhibition rather than activation of Kir3 channels (Margeta-Mitrovic et al., 2001a) . Similar observations were made in a related study (Galvez et al., 2001) .
It is not ruled out that the baclofen-induced inward current is also present in wild-type CA1 pyramidal cells, in which it would be masked by simultaneous larger outward currents activated by heteromeric GABA B(1,2) receptors. Unfortunately, because we lack ligands that distinguish molecular subtypes of GABA B receptors, genetic manipulation is currently the only means to functionally dissociate native GABA B assemblies with and without a GABA B(2) subunit. Regardless of whether the baclofen-induced current seen in GABA B(2) Ϫ/Ϫ CA1 neurons is a consequence of the knock-out situation or not, the observation of a functional GABA B receptor in the absence of GABA B (2) Ϫ/Ϫ may be impor- Ϫ/Ϫ mice. During a 1 hr observation period, GABA B(2) knock-out mice (Ϫ/Ϫ) moved over significantly longer distances (left histogram) with significantly greater speed (right histogram) than heterozygous (ϩ/Ϫ) and wild-type (ϩ/ϩ) control mice. n ϭ 7-8 per genotype; mean Ϯ SEM; *p Ͻ 0.05. B, Response latencies of wild-type (ϩ/ϩ), heterozygous (ϩ/Ϫ), and GABA B(2) knock-out (Ϫ/Ϫ) mice in the hotplate test assessed at 55°C. GABA B(2) Ϫ/Ϫ mice show significantly reduced paw-lick latencies compared with wild-type and heterozygous control groups. n ϭ 19 -20 per genotype; mean Ϯ SEM; ***p Ͻ 0.001. C, Response latencies of wild-type (ϩ/ϩ), heterozygous (ϩ/Ϫ), and GABA B(2) knock-out (Ϫ/Ϫ) mice in the tail-flick test assessed at infrared intensity 14. GABA B(2) Ϫ/Ϫ mice show significantly reduced tail-flick latencies compared with wild-type and heterozygous control groups. n ϭ 19 -21 per group; mean Ϯ SEM; *p Ͻ 0.05. D, Paw-withdrawal thresholds for wild-type (ϩ/ϩ), heterozygous (ϩ/Ϫ), and GABA B(2) knock-out (Ϫ/Ϫ) mice in response to a mechanical stimulus. Withdrawal thresholds of the left hindpaw were assessed for each genotype. GABA B(2) Ϫ/Ϫ mice show a significantly reduced withdrawal threshold compared with wild-type and heterozygous control groups. n ϭ 19 -21 per group; ***p Ͻ 0.001. Nociception tests were analyzed with Tukey's honestly significant difference test. In all tests, there were no significant differences in the behavior of wild-type or heterozygous mice. E, Impaired passive avoidance learning in GABA B(2) Ϫ/Ϫ mice.
Step-through latencies of wild-type (ϩ/ϩ) and GABA B(2) knock-out (Ϫ/Ϫ) mice into the dark (shock) compartment on the training day (white bars) and in the retention test (black bars). GABA B(2) Ϫ/Ϫ mice were slower to enter on training day but faster in the retention test compared with the wild-type control mice. Wild-type, but not GABA B(2) Ϫ/Ϫ , mice show significantly longer latencies to enter the dark compartment in the retention test compared with the training trial, which is taken as an index of memory of the initial experience. n ϭ 6 -11 per group; mean Ϯ SEM; ***p Ͻ 0.001 versus training; #p Ͻ 0.05 versus genotype; ##p Ͻ 0.01 versus genotype.
tant. An increasing number of studies suggest that various cellular populations in the nervous system express GABA B(1) without GABA B(2) (Billinton et al., 2000; Calver et al., 2000; Clark et al., 2000; Ng and Yung, 2001; Burman et al., 2003; Kim et al., 2003; Kulik et al., 2003; Li et al., 2003; Straessle et al., 2003) . Our results imply that neurons that naturally lack a GABA B(2) subunit nevertheless have the potential to express functional GABA B receptors. Unfortunately, it is currently impossible to identify such cells for electrophysiological recordings. This, together with the finding that the GABA B receptors seen in GABA B(2) Ϫ/Ϫ mice do not appear to be involved in classical GABA B functions, makes it currently difficult to address the possible physiological role of such receptors.
In conclusion, it clearly emerges that heteromeric GABA B(1,2) receptors are the prevalent GABA B receptors in the nervous system and that virtually all GABA B(2) protein is normally associated with GABA B(1) . However, our genetic experiments also suggest that GABA B(1) could be functional in neurons that naturally lack GABA B(2) expression.
